Sesen Bio Files Shelf for Up to $200 Million in Securities
03:08 AM EDT, 05/11/2021 (MT Newswires) -- Sesen Bio (SESN) on Monday filed a registration statement covering the potential sale of up to $200 million in securities.
The securities, which may be offered from time to time, include debt securities, common shares, preferred shares, depositary shares, warrants, rights and units, according to a filing with the US Securities and Exchange Commission.
Net proceeds from the sale will be used to fund the preparation for regulatory activities in support of obtaining the US Food and Drug Administration approval of Vicineum in the US.
Price: 2.3900, Change: -0.2800, Percent Change: -10.49